References

1. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science. 1997;275(5296):77-79.

2. Linehan MF, Frank TL, Hazell ML, et al. Is the prevalence of wheeze in children altered by neonatal BCG vaccination? J Allergy Clin Immunol. 2007;119(5):1079-1085.

3. von Mutius E, Pearce N, Beasley R, et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax. 2000;55(6):449-453.

4. Lighter-Fisher J, Peng C-H. Infection with Mycobacterium tuberculosis is inversely associated with childhood asthma. Pediatric allergy & immunology and pulmonology. 2012;25:80-85.

5. Obihara CC, Kimpen JL, Gie RP, et al. Mycobacterium tuberculosis infection may protect against allergy in a tuberculosis endemic area. Clin Exp Allergy. 2006;36(1):70-76.

6. Corrigall VM, Bodman-Smith MD, Fife MS, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001;166(3):1492-1498.

7. Brownlie RJ, Myers LK, Wooley PH, et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum. 2006;54(3):854-863.

8. Bodman-Smith MD, Corrigall VM, Kemeny DM, Panayi GS. BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals. Rheumatology (Oxford). 2003;42(5):637-644.

9. Kirkham B, Chaabo K, Hall C, et al. Safety and patient response as indicated by biomarker changes to binding immunoglobulin protein in the phase I/IIA RAGULA clinical trial in rheumatoid arthritis. Rheumatology (Oxford). 2016;55(11):1993-2000.

10. The Global Asthma Report: The Global Asthma Network; 2018. Available at: http://globalasthmareport.org/.

11. Table 13-10-0096-08 Asthma, by age group: Statistics Canada; 2018. Available at: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1310009608.

12. National Current Asthma Prevalence (2016): Centres for Disease Control and Prevention; 2018. Available at: https://www.cdc.gov/asthma/most_recent_data.htm.

13. Sole D, Aranda CS, Wandalsen GF. Asthma: epidemiology of disease control in Latin America – short review. Asthma Res Pract. 2017;3:4.

14. Song WJ, Kang MG, Chang YS, Cho SH. Epidemiology of adult asthma in Asia: toward a better understanding. Asia Pac Allergy. 2014;4(2):75-85.

15. Barbour KE, Helmick CG, Boring M, Brady TJ. Vital Signs: Prevalence of Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation – United States, 2013-2015. MMWR Morb Mortal Wkly Rep. 2017;66(9):246-253.

16. Hootman JM, Helmick CG, Barbour KE, Theis KA, Boring MA. Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015-2040. Arthritis Rheumatol. 2016;68(7):1582-1587.